http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
Hybrid Veil-Like Co(OH)2/rGO Nanocomposites Towards Electrochemical Hydrogen Storage Properties
Keda Wang,Jing Yu,Lijun Liu,Lin Hou,Fengyou Jin 성균관대학교(자연과학캠퍼스) 성균나노과학기술원 2017 NANO Vol.12 No.11
The design and synthesis of new hydrogen storage nanomaterials with high capacity at low cost is extremely desirable but remains challenging for today's development of a hydrogen economy. As a new type hydrogen storage material, Co(OH)2/rGO nanocomposites were successfully obtained through a facile method in this study. Through the measurements of X-ray diffraction, X-ray photoelectron spectroscopy (XPS), scanning electron microscopy (SEM), transmission electron microscopy (TEM), cyclic voltammetry and galvanostatic charge/discharge, it indicated that Co(OH)2/rGO nanocomposites showed a veil-like microstructure, consisting of interlaced nanorods with a diameter of 4–8 nm on rGO nanosheets. The hydrogen storage capacity was up to 400 mAh/g at room temperature, higher than those of graphene and Co(OH)2.
Litong Yao,Xiaoyan Liu,Mozhi Wang,Keda Yu,Shouping Xu,Pengfei Qiu,Zhidong Lv,Xinwen Zhang,Yingying Xu 한국유방암학회 2023 Journal of breast cancer Vol.26 No.2
Purpose: We aimed to identify effectiveness-associated indicators and evaluate the optimal tumor reduction rate (TRR) after two cycles of neoadjuvant chemotherapy (NAC) in patients with invasive breast cancer. Methods: This retrospective case-control study included patients who underwent at least four cycles of NAC at the Department of Breast Surgery between February 2013 and February 2020. A regression nomogram model for predicting pathological responses was constructed based on potential indicators. Results: A total of 784 patients were included, of whom 170 (21.68%) reported pathological complete response (pCR) after NAC and 614 (78.32%) had residual invasive tumors. The clinical T stage, clinical N stage, molecular subtype, and TRR were identified as independent predictors of pCR. Patients with a TRR > 35% were more likely to achieve pCR (odds ratio, 5.396; 95% confidence interval [CI], 3.299–8.825). The receiver operating characteristic (ROC) curve was plotted using the probability value, and the area under the ROC curve was 0.892 (95% CI, 0.863–0.922). Conclusion: TRR > 35% is predictive of pCR after two cycles of NAC, and an early evaluation model using a nomogram based on five indicators, age, clinical T stage, clinical N stage, molecular subtype, and TRR, is applicable in patients with invasive breast cancer.